The pathogenesis of recurrent Clostridium difficile infection (CDI) is still poorly understood.
The risk of recurrence is approximately 20% after an initial CDI episode and dramatically …

Study Objective Prior studies have identified risk factors for recurrent Clostridium difficile
infection (CDI), but few studies have integrated these factors into a clinical prediction rule …

Clostridium difficile infection (CDI) is increasingly prevalent, dangerous and challenging to
prevent and manage. Despite intense national and international attention the incidence of …

BACKGROUND & AIMS: Prevention of recurrent Clostridium difficile infection (CDI) is a
substantial therapeutic challenge. A previous prospective study of 63 patients with CDI …

Clostridium difficile is the most frequent cause of nosocomial antibiotic-associated diarrhea.
The incidence of C. difficile infection (CDI) has been rising worldwide with subsequent …

Abstract Background Recurrent Clostridium difficile infection (rCDI) places a huge economic
and practical burden on healthcare facilities. Furthermore, rCDI may affect quality of life …

OBJECTIVEAn estimated 20–30% of patients with primary Clostridium difficile infection
(CDI) develop recurrent CDI (rCDI) within 2 weeks of completion of therapy. While the actual …

Recurrence occurs in approximately 25% of all cases of Clostridium difficile infection (CDI)
and poses a unique clinical challenge. Traditionally, treatment options of CDI have been …

Clostridium difficile is the leading infectious cause of antibiotic‐associated diarrhea and
colitis. C. difficile infection (CDI) places a heavy burden on the healthcare system, with …

Clostridium difficile infection (CDI) remains a substantial burden on healthcare systems and
is likely to remain so given our reliance on antimicrobial therapies to treat bacterial …